Directory

>

Samuel Waksal

avatar

Samuel Waksal

Chief Executive Officer | MeiraGTx

New York, New York, United States

View contact details (it's free)

Samuel Waksal

Summary

Samuel Waksal is a prominent immunologist and entrepreneur based in New York, recognized for his significant contributions to the biotechnology sector. He has founded multiple companies, including ImClone Systems and Kadmon Biopharmaceuticals, where he has played a pivotal role in the development of groundbreaking therapies for autoimmune diseases and cancer. With a strong academic background in immunology, he is also an influential speaker, delivering lectures globally on innovation in science and cancer biology. His expertise spans various fields including neuroscience and tumor immunology, making him a well-rounded figure in the pharmaceutical industry. Samuel's work is characterized by a commitment to advancing medical research and improving patient outcomes through innovative treatments. He has a proven track record in R&D, having developed key drugs like Erbitux and Cyramza. Samuel continues to lead initiatives that aim to cure diseases by restoring immune system homeostasis.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Startup Experience

Corporate Experience

Samuel Waksal

Work Experience

💼

Chief Executive Officer at

GRAVITON BIOSCIENCE LIMITED

January 2022 - Present

💼

Chairman Chief executive Officer and President at

Graviton Biopharmaceuticals

January 2020 - Present

company logo

Visiting Fellow at

BRAIN-MIND INSTITUTE

January 2018 - Present

💼

Visiting Fellow at

Appel Alzheimers Research Institure Weill Cornell Medicine

June 2016 - Present

company logo

Founder and founding chairman at

MeiraGTx

January 2015 - Present

💼

Founder Equilibre Neuroscience corporation at

Equilibre Holding

June 2019 - January 2023

company logo

Founder Chairman Chief Science Innovation Strategy at

Kadmon

September 2014 - February 2016

company logo

Founder at

Kadmon

January 2010 - February 2016

company logo

Founder Chairman Chief Executive Officer at

Kadmon

January 2010 - January 2016

company logo

Founder Chairman CEO at

Kadmon

January 2010 - September 2014

💼

Founder CEO President at

Imclone Systems

January 1985 - January 2002

Logos provided by Logo.dev

Samuel Waksal

Education

The Ohio State University College of Medicine, Doctorate

Frequently Asked Questions about Samuel Waksal

What company does Samuel Waksal work for?

Samuel Waksal is a Chief Executive Officer at MeiraGTx, a company specializing in Commercial physical research.

Where Samuel Waksal graduated from?

Samuel Waksal holds a degree in Immunology from The Ohio State University College of Medicine.

Who is Samuel Waksal?

Samuel Waksal is a prominent immunologist and entrepreneur based in New York, recognized for his significant contributions to the biotechnology sector. He has founded multiple companies, including ImClone Systems and Kadmon Biopharmaceuticals, where he has played a pivotal role in the development of groundbreaking therapies for autoimmune diseases and cancer. With a strong academic background in immunology, he is also an influential speaker, delivering lectures globally on innovation in science and cancer biology. His expertise spans various fields including neuroscience and tumor immunology, making him a well-rounded figure in the pharmaceutical industry. Samuel's work is characterized by a commitment to advancing medical research and improving patient outcomes through innovative treatments. He has a proven track record in R&D, having developed key drugs like Erbitux and Cyramza. Samuel continues to lead initiatives that aim to cure diseases by restoring immune system homeostasis.

Samuel`s contact details

Colleagues

avatar
Tassos Georgiadis

Vice President Preclinical Development

avatar
Richard Giroux

Chief Operating Officer

avatar
Robert Zeldin

Chief Medical Officer

avatar
Michael Passineau

Vice President, Salivary Gland Therapeutics Lead

Kysler De Guzman

Executive Director, CMC Regulatory Affairs

avatar
Jun Liu

VP, Biostatistics

Michael Boxer

VP Clinical Research and Ophthalmology

avatar
David Rubinstein

Senior Vice President, Head of Business Development

View Contact details (it's free)
Request Profile Removal